Dr. Ranganathan joined the RadioMedix in 2012 and currently serves as Director for CMC and Regulatory Affairs. Extensive experience in translational oncology research, managing CMOs/CROs and clinical drug development for several agents. Authored CMC sections and managed regulatory submissions to FDA and other health authorities to support 8 INDs and 1 NDA to date. Hands on experience in setting up and managing a Radiopharmaceutical manufacturing facility and also led multiple tech transfer programs which have translated into clinical trial supply. He has been a co-author on several scientific articles for peer-reviewed journals and conference papers. He received a M.Sc. in chemistry from University of Madras, a PhD in Chemical sciences from University of Camerino, and completed a postdoctoral fellowship in Radiological Sciences at Washington University School of Medicine in Saint Louis.